This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inoue, Y. Articles by Newman, L. S. Search for Related Content PubMed PubMed Citation Articles by Inoue, Y. Articles by Newman, L. S.

Basic Fibroblast Growth Factor and Its Receptors in Idiopathic Pulmonary Fibrosis and Lymphangioleiomyomatosis

Division of Environmental and Occupational Health Sciences and Pulmonary Division, Department of Medicine, National Jewish Medical and Research Center; Division of Pulmonary Science and Critical Care Medicine, Department of Medicine and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado; Department of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Kinki-Chuo Hospital for Chest Diseases, Osaka, Japan; and Department of Medicine, San Francisco General Hospital, San Francisco, California

Correspondence and requests for reprints should be addressed to Yoshikazu Inoue, M.D., Ph.D., Department of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Kinki-Chuo Hospital for Chest Diseases, 1180 Nagasone-cho, Sakai, Osaka 591-8555, Japan. E-mail: giichi{at}kch.hosp.go.jp

Basic fibroblast growth factor (bFGF) is a potent mitogenic factor for smooth muscle cells, myofibroblasts, and fibroblasts, proliferation of which is a hallmark of idiopathic pulmonary fibrosis (IPF) and lymphangioleiomyomatosis (LAM). Mast cells produce bFGF and have been associated with pulmonary fibrosis. We hypothesize that smooth muscle cell/myofibroblast–like cells will be spatially associated with bFGF-containing mast cells and that bFGF receptors will be expressed on the effector cells in IPF and LAM. We performed quantitative immunohistochemistry for bFGF, mast cell tryptase, smooth muscle actin for smooth muscle cell/myofibroblast–like cells, and fibroblast growth factor receptors (Flg, Bek) and measured collagen and elastic fiber in lung sections from IPF (n = 14), LAM (n = 9), and control lung (n = 10). IPF and LAM lung contained more smooth muscle cell/myofibroblast–like cells than did control lung. bFGF-containing mast cells were abundant both in IPF and LAM and were associated with collagen, elastic fibers, and smooth muscle cell/myofibroblast–like cells in IPF. Flg was expressed on epithelial cells, endothelial cells, smooth muscle cell/myofibroblast–like cells, and macrophages in IPF. In LAM, Flg was expressed on epithelial cells adjacent to smooth muscle cell/myofibroblast–like cell aggregates. Bek was expressed dominantly on smooth muscle cell/myofibroblast–like cells in LAM and on smooth muscle cell/myofibroblast–like cells as well as neutrophils in IPF. These data suggest that mast cell–derived bFGF might exert fibrogenic, proliferative effects on smooth muscle cell/myofibroblast–like cells through its receptors.

Key Words: mast cells • extracellular matrix • myofibroblasts • fibroblast growth factor receptors • lung

This article has been cited by other articles:

				J. C. Valencia, G. Pacheco-Rodriguez, A. K. Carmona, J. Xavier, P. Bruneval, W. K. Riemenschneider, Y. Ikeda, Z.-X. Yu, V. J. Ferrans, and J. Moss Tissue-Specific Renin-Angiotensin System in Pulmonary Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 40 - 47. [Abstract] [Full Text] [PDF]

				F. Guddo, A. M. Vignola, M. Saetta, S. Baraldo, L. Siena, E. Balestro, R. Zuin, A. Papi, P. Maestrelli, L. M. Fabbri, et al. Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Eur. Respir. J., May 1, 2006; 27(5): 957 - 963. [Abstract] [Full Text] [PDF]

				S R Atkins, E L Matteson, J L Myers, J H Ryu, and T Bongartz Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia. Ann Rheum Dis, May 1, 2006; 65(5): 677 - 680. [Abstract] [Full Text] [PDF]

				W. Matsuyama, M. Watanabe, Y. Shirahama, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura Discoidin Domain Receptor 1 Contributes to the Survival of Lung Fibroblast in Idiopathic Pulmonary Fibrosis Am. J. Pathol., March 1, 2006; 168(3): 866 - 877. [Abstract] [Full Text] [PDF]

				J. L. Black, Q. Ge, S. Boustany, P. R. A. Johnson, M. H. Poniris, A. R. Glanville, B. G. G. Oliver, L. M. Moir, and J. K. Burgess In vitro studies of lymphangioleiomyomatosis Eur. Respir. J., October 1, 2005; 26(4): 569 - 576. [Abstract] [Full Text] [PDF]

				N. Khalil and R. O'Connor Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment Can. Med. Assoc. J., July 20, 2004; 171(2): 153 - 160. [Abstract] [Full Text] [PDF]

				G. Finlay The LAM cell: what is it, where does it come from, and why does it grow? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L690 - L693. [Full Text] [PDF]

				K. E. Sietsema and F. X. McCormack Lymphangioleiomyomatosis: Insights about, and from, a Rare Disease Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1405 - 1406. [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF]